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The dystrophin-glycoprotein complex is a novel laminin receptor in skeletal muscle. Dystrophin-associated proteins are comprised of an extracel- 
lular glycoprotein of 156 kDa (156DAG), transmembrane glycoproteins of 50 kDa (SODAG), 43 kDa (43DAG) and 35 kDa (35DAG), and a 
cytoskeletal protein of 59 kDa (59DAP). The laminin-binding 156DAG and 43DAG are encoded by a single gene and are now called a- and 
/I-dystroglycan, respectively. In neuromuscular junctions, utrophin, an autosamal homologue of dystrophin, is associated with sarcolemmal proteins 
identical or immunologically homologous to the dystrophin-associated proteins. Here we demonstrate the co-localization of Dpl16 (a 116 kDa 
protein product of the DMD gene), full-size utrophin, u- and p-dystroglycan, 59DAP and 35DAG in a thin rim surrounding the outermost layer 
of myehn sheath of peripheral nerve fibers. The a-dystroglycan in peripheral nerve had molecular weight of 120 kDa instead of 156 kDa, suggesting 
different levels of glycosylation between skeletal muscle and peripheral nerve. In sharp contrast to skeletal muscle, however, full-size dystrophin 
and SODAG were undetectable in peripheral nerve. Our results demonstrate the varied expression of the components of the dystrophimutrophin- 
glycoprotein complex between skeletal muscle and peripheral nerve suggesting the complex may exist in varied compositions and have varied 
functions in these two tissues. 
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1. INTRODUCTION 
Dystrophin is a large cytoskeletal protein encoded by 
the Duchenne muscular dystrophy (DMD) gene [1,2]. 
In skeletal muscle, dystrophin exists in a large oligo- 
merit complex tightly associated with an extracellular 
glycoprotein of 156 kDa (156DAG), transmembrane 
glycoproteins of 35 kDa (35DAG), 43 kDa (43DAG) 
and 50 kDa (SODAG), and a cytoskeletal protein of 59 
kDa (59DAP) [3-71. The 156DAG and 43DAG are en- 
coded by a single gene and these proteins are now called 
CI- and B-dystroglycan, respectively [8,9]. The a-dystro- 
glycan (156DAG) binds laminin, a major protein com- 
ponent of the extracellular matrix [8]. It is heavily glyco- 
sylated, two-thirds of its molecular mass being ac- 
counted for by sugar residues [8]. The glycoprotein- 
binding site exists in the cysteine-rich/C-terminal do- 
mains of dystrophin [lO,l I]. Dystrophin also interacts 
with F-actin through the actin-binding site(s) in the N- 
terminal domain [12-141. These findings indicate that 
the dystrophin-glycoprotein complex spans the sar- 
colemma to link the subsarcolemmal ctin-cytoskeleton 
with the extracellular matrix [7,8]. 
Utrophin (previously called dystrophin-related pro- 
tein or DRP), an autosomal homologue of dystrophin, 
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is localized exclusively to the neuromuscular junction in 
adult skeletal muscle [15,16]. Utrophin has cysteine- 
rich C-terminal domains which are highly homologous 
to those of dystrophin [15]. In the neuromuscular junc- 
tion, utrophin exists in a protein complex homologous 
to the dystrophin-glycoprotein complex, suggesting 
that the utrophin-glycoprotein complex may have simi- 
lar function(s) to the dystrophin-glycoprotein complex 
in this specialized region of sarcolemma [17]. 
Recently distal transcripts of the DMD gene have 
been identified and their protein products have been 
shown to be expressed ifferently from the full-size 400 
kDa dystrophin [18-231. A protein of 71 kDa called 
Dp71 (also called apo-dystrophin-1) is expressed in 
non-muscle tissues, such as brain, liver and gut [18-221. 
A protein of 116 kDa called Dpl16 has been reported 
to be expressed in Schwann cells of peripheral nerve 
[23]. While the physiological functions of these proteins 
remain unknown, the fact that both Dp71 and Dpll6 
share the cysteine-rich/C-terminal domains of dystro- 
phin which are involved in the interaction with the 
glycoprotein complex, suggested apossibility that Dp71 
and Dp116 could exist in a complex similar to the 
dystrophin-glycoprotein complex of skeletal muscle 
[18-233. The elucidation of the physiological functions 
of these newly identified DMD gene products and their 
potential protein complexes could provide insight into 
the molecular mechanism of nervous system dysfunc- 
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tion frequently observed in DMD patients. In the pres- 
ent study, we investigated the status of expression of 
dystrophin, utrophin and the dystrophin-associated 
proteins in peripheral nerve. 
2. MATERIALS AND METHODS 
2.1. Antibodies 
The following monoclonal antibodies against distinct domains of 
dystrophin were used in this study: AlC, against amino acid residues 
215-264 [24,25]; VIAq, against he cysteine-rich/C-terminal domains 
[6,7,11,26,27]; and DYS2 against he last 17 amino acids (Novocastra 
Laboratories). Two antibodies against the C-terminus of utrophin 
were used: affinity-purified rabbit antibody against he last 12 amino 
acids [16,17], and a monoclonal antibody, DRPl, against he last 11 
amino acids (Novocastra Laboratories). Sheep antibodies against 
156DAG, 59DAP, SODAG, 43DAG and 35DAG were affinity-puri- 
fied as described [2628]. IIH6, a monoclonal antibody against 
156DAG, and IVD3,, a monoclonal antibody against SODAG, were 
characterized previously [4,6-8,27,28]. 
Fig. 1. Immunohistochemical nalysis of the DMD gene products and utrophin in rabbit sciatic nerve. 7;um thick transverse cryosections from 
rabbit sciatic nerve were immunostained with monoclonal antibodies against distinct domains of dystrophin (VIAq, DYS2 and AlC) and utrophin 
(DRPI). Phase-contrast images of the same visual field are shown on the right. VIA4,. DYS2 and DRPl stained a thin rim surrounding the 
outermost layer of myelin sheath of nerve fibers. AlC gave no signal. Bar = 20 pm. 
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2.2. Immunohistochemistry 
After sacrificing a rabbit, skeletal muscle and sciatic nerve were 
excised immediately, snap-frozen in isopentane cooled in liquid nitro- 
gen and stored at -80°C until use. Indirect immunofluorescence mi- 
croscopy of 7 pm-thick cryosections from rabbit skeletal muscle and 
sciatic nerve was performed as described previously [26-281. 
2.3. 3-12% SDS-PAGE and immunoblot analysis 
Cryosections from rabbit skeletal muscle and sciatic nerve were 
extracted in 50 ~01s. of SDS-buffer as described previously [17,28]. 
3-12% SDS-PAGE and immunoblotting were performed as described 
[3,4]. 25 and 125 ,uI of SDS-extracts were applied for Coomassie blue 
staining of the gel and immunoblotting, respectively. 
3. RESULTS AND DISCUSSION 
Immunohistochemistry demonstrated intense stain- 
ing of rabbit sciatic nerve by antibodies against the 
C-terminal domains of dystrophin, VIA4, and DYS2 
(Fig. I). Staining was positive in a thin rim surrounding 
the outermost layer of myelin sheath of nerve fibers, as 
revealed by phase contrast images of the same visual 
field (Fig. 1). Antibody against the N-terminal domain 
of dystrophin, AIC, gave no signal (Fig. 1). Antibody 
against the C-terminus of utrophin, DRPl, also stained 
a thin rim surrounding the outermost layer of myelin 
sheath of nerve fibers (Fig. 1). The same staining pat- 
tern was obtained with antibodies against 156DAG, 
59DAP, 43DAG and 35DAG (Fig. 2). In sharp con- 
trast, antibody against SODAG did not stain peripheral 
nerve (Fig. 2). 
On immunoblot analysis of SDS extracts of rabbit 
sciatic nerve, antibodies against he C-terminal domains 
of dystrophin, VIAq and DYS2, stained a band with 
a molecular weight of 110-120 kDa, but full-size 400 
kDa dystrophin was not detected (Fig. 3). This 110-120 
kDa band was not stained by antibody against the N- 
terminal domain of dystrophin, AlC (Fig. 3). These 
findings, together with the immunohistochemical data 
described above, indicated that this 110-120 kDa band 
was Dpl16, a recently-identified protein product of the 
3’ region of the DMD gene [23]. Affinity-purified anti- 
body against the C-terminus of utrophin, on the other 
hand, stained full-size 400 kDa utrophin in peripheral 
nerve (Fig. 3). Multiple bands with lower molecular 
weight were also stained weakly by this antibody (Fig. 
3). These bands could be proteolytic fragments of utro- 
phin or alternative protein products encoded by the 3’ 
region of the utrophin gene [19]. 
Antibody against 156DAG stained a band of 120 
kDa in sciatic nerve, while it stained a band of 156 kDa 
in skeletal muscle (Fig. 4). Antibody against 43DAG 
stained a band of 43 kDa in both skeletal muscle and 
sciatic nerve (Fig. 4). However, antibody against 
SODAG did not stain a band in sciatic nerve while it 
stained a band of 50 kDa in skeletal muscle (Fig. 4). 
Antibodies against 59DAP and 35DAG were not strong 
enough to produce conclusive results in this experiment 
(not shown). 
Here we demonstrated the co-localization of Dpl16, 
utrophin, dystroglycan, 59DAP and 35DAG in a thin 
rim surrounding the outermost layer of myelin sheath 
of peripheral nerve fibers. We also demonstrated that 
the a-dystroglycan (156DAG) had molecular weight of 
120 kDa in peripheral nerve. Recently it has been shown 
that the ol-dystroglycan has molecular weight of 120 
kDa in brain [8,29], and that a laminin-binding brain 
protein of 120 kDa called LBP120 has an amino acid 
sequence identical to ol-dystroglycan [30], raising the 
possibility that the ol-dystroglycan might be glycosyl- 
ated to different levels between skeletal muscle and 
brain. Our results suggest that the a-dystroglycan in 
peripheral nerve might have a similar glycosylation pat- 
tern as the brain form. In any case, the demonstration 
of laminin-binding dystroglycan in a restricted region of 
peripheral nerve could stimulate research to elucidate 
its function in the development and maintenance of the 
structural organization of peripheral nerve. 
In sharp contrast to skeletal muscle, full-size dystro- 
phin and SODAG were undetectable in peripheral nerve 
by both immunohistochemical nd immunoblot analy- 
ses. Although the failure to detect SODAG in peripheral 
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Fig. 2. Immunohistochemical nalysis of the dystrophin-associated proteins in rabbit sciatic nerve. 7-pm thick transverse cryosections from rabbit 
sciatic nerve were immunostained with a monoclonal antibody against SODAG, IVD3,, and affinity-purified antibodies against 156DAG, 59DAP, 
43DAG and 35DAG. Antibodies against 156DAG, 59DAP, 43DAG and 35DAG stained a thin rim surrounding the outermost layer of myelin 
sheath of nerve fibers. Antibody against SODAG gave no signal. Bar = 20 pm. 
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Fig. 3. Immunoblot analysis of the DMD gene products and utrophin 
in rabbit sciatic nerve. SDS extracts of rabbit skeletal muscle and 
sciatic nerve were separated by 3312% SDS-PAGE and immunoblot- 
ted with monoclonal antibodies against distinct domains of dystrophin 
(DYS2, VIA4* and AlC) and affinity-purified antibody against the 
C-terminus of utrophin (C’-DRP). CB shows the gel stained with 
Coomassie blue. DYS2 detected full-size 400 kDa dystrophin in skel- 
etal muscle and a band of 110-120 kDa in sciatic nerve. VIAq also 
detected a band of 1 lo-120 kDa in sciatic nerve, while AlC did not 
stain this 110-120 kDa band. C’-DRP detected full-size 400 kDa 
utrophin in sciatic nerve, together with less intensely stained bands of 
lower molecular weight. Molecular weight standards (Da x 10m3) are 
shown on the left. 
nerve in this study could be explained by different levels 
of glycosylation of this protein between skeletal muscle 
and peripheral nerve, our findings raise an intriguing 
possiblity that the putative complex, which could in- 
volve Dp116, utrophin and the dystrophin-associated 
proteins, may lack SODAG in peripheral nerve. The 
clarification of this putative complex and identification 
of its components await further biochemical investiga- 
tion. 
Recently we have demonstrated the specific defi- 
ciency of SODAG in sarcolemma of patients with severe 
childhood autosomal recessive muscular dystrophy 
with DMD-like phenotype (SCARMD) [28], and the 
deficiency in all the dystrophin-associated proteins, in- 
cluding SODAG, in sarcolemma of DMD patients [27]. 
These findings suggested that the deficiency of the 
SODAG may be the common denominator leading to 
muscle cell necrosis in these two diseases. Interestingly, 
SCARMD patients never present with the nervous sys- 
tem dysfunction which is found in a substantial percent- 
age of DMD patients. Taking our results into consider- 
ation, one hypothesis to explain this phenotypic differ- 
ence could be that SODAG is not expressed in nervous 
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Fig. 4. Immunoblot analysis of the dystrophin-associated proteins in 
rabbit sciatic nerve. SDS-exrtracts of rabbit skeletal muscle and sciatic 
nerve were separated by 3-12% SDS-PAGE and immunoblotted with 
IIH6, a monoclonal antibody against 156DAG (upper panel), and a 
cocktail of affinity-purified antibodies against SODAG and 43DAG 
(lower panel). IIH6 stained a band of 120 kDa in sciatic nerve, while 
it stained a band of 156 kDa in skeletal muscle. Antibody agamst 
43DAG stained a band of 43 kDa in both skeletal muscle and sciatic 
nerve. Antibody against SODAG did not stain a band in sciatic nerve, 
while it stained a band of 50 kDa in skeletal muscle. Antibodies against 
59DAP and 35DAG were not strong enough to produce conclusive 
results in this experiment. 
system and thus, its specific deficiency causes only mus- 
cular dysfunction in SCARMD. It would be of utmost 
importance to clarify whether SODAG is expressed in 
brain. 
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